Page 62 - ITPS-8-1
P. 62

INNOSC Theranostics and
            Pharmacological Sciences                                               Opioid use among Nigerian students



            10.  Nelson E, Alichie B. Chronic pain and prescription      doi: 10.1016/j.ypmed.2019.02.018
               opioid use among socially marginalized Nigerian women:   20.  McCabe S, West B, Veliz P, McCabe V, Stoddard S, Boyd  C.
               Exploring supply channels and pathways to misuse. J Drug   Trends  in  medical  and  nonmedical  use  of  prescription
               Issues. 2022;52(4):473-487.                        opioids among us adolescents: 1976-2015.  Pediatrics.
               doi: 10.1177/00220426221083655                     2017;139(4):e20162387.
            11.  Nnachi O, Akpa C, Nwani F, Edenya O. Pentazocine misuse      doi: 10.1542/peds.2016-2387
               among sickle cell disease patients and the role of lack of   21.  Dumbili E, Ezekwe E, Odeigah O. From “codeine diet” to
               enforcement of opioid dispensing regulations by community   “gutter water”: Polydrug use among Nigerian young adults.
               pharmacies: A descriptive observational study. Adv Public   Drugs Alcohol Today. 2020;20(2):95-107.
               Health. 2022;2022:3877882.
                                                                  doi: 10.1108/dat-02-2020-0003
               doi: 10.1155/2022/3877882
                                                               22.  Hout M. “Doctor shopping and pharmacy hopping”:
            12.  Rahman A, Walia N, Sahakian Y, Khaliq T, Cukovic L.   Practice innovations relating to codeine.  Drugs Alcohol
               Pharmacy students’ attitude towards opioid epidemic and   Today. 2014;14(4):219-234.
               overdose  management.  World J Biol Pharm Health Sci.      doi: 10.1108/dat-03-2014-0014
               2022;9(3):6-12.
                                                               23.  Oshodi O, Aina O, Onajole A. Substance use among
               doi: 10.30574/wjbphs.2022.9.3.0045
                                                                  secondary school students in an urban setting in Nigeria:
            13.  Tompach PC, Vincent  S, Peterson  A, Tu HK, Born DO.   Prevalence and associated factors.  Afr J Psychiatry.
               A dental school survey assessing dental student knowledge,   2010;13(1):52-57.
               attitudes and prescribing behavior regarding opioid use and      doi: 10.4314/ajpsy.v13i1.53430
               misuse. J Dental Sci Res Rep, 2021;3:1-6.
                                                               24.  Choo K, Rishya A, Manikam L, Yoong K, Kandasamy  VA.
               doi: 10.47363/jdsr/2021(3)111                      Prophylactic  metoclopramide  use  in  trauma  patients
            14.  Dompreh HO, Lynch M, Longworth M. A  systematic   given tramadol: A  randomised, double-blinded, placebo-
               review exploring the impact of socio-cultural factors on   controlled trial. Hong Kong J Emerg Med. 2018;26(2):98-105.
               pain management approaches in Saharan Africa.  Medrxiv      doi: 10.1177/1024907918789586
               [Preprint]; 2022.
                                                               25.  Raehal K, Schmid C, Groer C, Bohn L. Functional
               doi: 10.1101/2022.04.11.22273701                   selectivity at the  μ-opioid receptor: implications for
            15.  Aboluwarin A. Management of opioid use disorder in   understanding opioid analgesia and tolerance.  Pharmacol
               sickle cell anaemia amidst growing menace in the general   Rev. 2011;63(4):1001-1019.
               population. Open J Pediatr. 2023;13(6):807-820.     doi: 10.1124/pr.111.004598
               doi: 10.4236/ojped.2023.136089                  26.  Nee J, Rangan V, Lembo A. Reduction in pain: Is it worth the
            16.  Nelson E, Odeigah O, Dumbili E. Tramadol regulation,   gain? The effect of opioids on the GI tract. Neurogastroenterol
               illegal markets and consumption practices: Exploring   Motil. 2018;30(5):e13367.
               frictions of drug control in Nigeria. Drugs Habits Soc Policy.      doi: 10.1111/nmo.13367
               2023;24(4):296-309.
                                                               27.  Nelson A, Camilleri M. Chronic opioid-induced constipation
               doi: 10.1108/dhs-12-2022-0051                      in patients with nonmalignant pain: Challenges and
                                                                  opportunities. Ther Adv Gastroenterol. 2015;8(4):206-220.
            17.  Dic-Ijiewere EO, Osadolor HB. Cyp24a1 and cyp3a4 levels,
               renal, and hepatic changes, and incidence of oxidative      doi: 10.1177/1756283x15578608
               stress in tramadol-alcohol concomitant misuse.  Cureus.   28.  Whang B, Jeong S, Leem J, Kim Y. Aspiration pneumonitis
               2023;15:e36877.                                    is caused by delayed respiratory depression following
               doi: 10.7759/cureus.36877                          intrathecal morphine administration.  Korean J Pain.
                                                                  2012;25(2):126-129.
            18.  Jones C, Clayton H, Deputy N,  et al. Prescription opioid
               misuse and use of alcohol and other substances among high      doi: 10.3344/kjp.2012.25.2.126
               school students - youth risk behaviour survey, United States,   29.  Żurek U. Opioid-induced bowel dysfunction: A  literature
               2019. MMWR Suppl. 2020;69(1):38-46.                review. J Educ Health Sport. 2023;22(1):147-164.
               doi: 10.15585/mmwr.su6901a5                        doi: 10.12775/jehs.2023.22.01.012
            19.  Han B, Sherman S, Palamar J. Prescription opioid misuse   30.  Hough L, Nalwalk J, Cleary R,  et  al. Deficits in neuronal
               among middle-aged and older adults in the United States,   cytochrome p450 activity attenuate opioid analgesia but not
               2015-2016. Prev Med. 2019;121:94-98.               opioid side effects. Eur J Pharmacol. 2014;740:255-262.


            Volume 8 Issue 1 (2025)                         56                               doi: 10.36922/itps.3894
   57   58   59   60   61   62   63   64   65   66   67